Adam Gregory

Adam Gregory
Adam is an Associate Patent Attorney in our life sciences team. He works predominantly in the biotechnology sector and with clients based in Singapore, the US and Europe. Adam is a regular visitor to Singapore, and his clients include Tessa Therapeutics, Hummingbird Bioscience and Enleofen Bio amongst others.

Recent Posts

T cell engagers - dark horses of immunotherapy

Adam Gregory

Adam Gregory
26 Sep 2019

Chimeric antigen receptor (CAR) technology has attracted a lot of attention and investment in recent years, but the potential of T cell Engager.

Cultured meat - food for thought

Adam Gregory

Adam Gregory
23 Jul 2019

Cultured meat is rapidly emerging alongside plant-and microorganism-based alternative meat products as a future ‘clean meat’.  It is made by growing.

Singapore biotech start-ups: the importance of patent protection

Adam Gregory

Adam Gregory
21 Jun 2019

Singapore’s biotech industry plays a key role in shaping the country’s future economy. This is largely thanks to an initiative launched in 2000 aimed.

Precision therapeutics for the precision medicine era

Adam Gregory

Adam Gregory
17 May 2019

In recent years we have seen dramatic advances in our understanding of the intricate and dynamic relationships that underpin our immune responses. This.

Patent protection: five tips for biotech start-ups

Adam Gregory

Adam Gregory
10 Dec 2018

Early-stage biotech companies are often founded based on the exciting results of pre-clinical research relating to a new product or treatment. However,.